Instrument Inactif

Communiqués Danaher Corporation NYSE

Actions

DHR PRB

US2358514097

Equipement et technologie médicale avancés

Communiqués

03/07	Did Danaher Corporation Insiders Breach their Fiduciary Duties to Shareholders?	PR
29/06	Danaher Foundation Commits $1 Million to Ebola Outbreak Relief Efforts in Central Africa	PR
22/06	Danaher Schedules Second Quarter 2026 Earnings Conference Call	PR
22/06	Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk Sooner	BU
10/06	Danaher Completes Acquisition of Masimo Corporation	PR
01/06	SCIEX Launches the novus V55 System With SCIEX OS 5.0 Software and AI Enablement Tools	BU
01/06	SCIEX Advances the ZenoTOF Line With Platform-Wide Expansions in Software, Integrations, and Key Collaborations	BU
06/05	Danaher to Present at Bank of America Securities Healthcare Conference	PR
05/05	Danaher Announces Quarterly Dividend	PR
23/04	Danaher Announces Pricing of Euro-Denominated Senior Notes Offering	PR
21/04	Danaher: Q1 Earnings Snapshot	AQ
21/04	Danaher : Quarterly Report for Quarter Ending March 27, 2026 (Form 10-Q)	PU
21/04	Danaher Reports First Quarter 2026 Results	PR
13/04	Beckman Coulter Diagnostics Earns CE Mark for New Assay Delivering Bacterial vs. Viral Infection Results in Approximately 20 Minutes	PR
10/04	Did Danaher Corporation Insiders Breach their Fiduciary Duties to Shareholders?	PR
23/03	Danaher Schedules First Quarter 2026 Earnings Conference Call	AQ
20/03	Danaher Schedules First Quarter 2026 Earnings Conference Call	PR
12/03	Did Danaher Corporation Insiders Breach their Fiduciary Duties to Shareholders?	PR
24/02	Danaher Announces Quarterly Dividend	PR
24/02	Danaher to Present at TD Cowen Health Care Conference	PR
17/02	Masimo to be Acquired by Danaher for $180.00 Per Share	BU
06/02	Danaher : Annual CDP Response (danaher corporation 2025 cdp response)	PU
28/01	Danaher: Q4 Earnings Snapshot	AQ
28/01	Danaher Reports Fourth Quarter and Full Year 2025 Results	PR
12/01	Danaher CEO to Comment on Financial Performance	PR